Raquel Pluvinet
Core Facility Leader
Biography
Raquel Pluvinet holds a degree in Biological Sciences and a PhD in Genetics from the University of Barcelona. She has extensive experience in molecular biology and genomics.
As a postgraduate researcher, she became familiar with molecular biology and Sanger sequencing techniques, participating in a cDNA sequencing project of the Euro-IMAGE Consortium for the molecular analysis of human transcripts led by Dr Xavier Estivill at the Centre for Medical and Molecular Genetics of the Institut de Recerca Oncològica (IRO).
She completed her doctoral thesis focused on the study of the molecular basis of the immuno-inflammatory process at the Centre for Medical and Molecular Genetics of IRO (2001-2007), in collaboration with the Microarrays Unit of the Centre for Genomic Regulation (CRG). During her postdoctoral stay in the Molecular Genetics group at the Bellvitge Biomedical Research Institute (IDIBELL) (2007-2009), she started working in the field of bioinformatics, using computational tools for the analysis of microarray data.
From 2009 to 2016 she worked as a technical specialist in the Genomics and Bioinformatics unit of the Institute of Predictive and Personalised Medicine of Cancer (IMPPC). Subsequently, from 2016 to August 2023, she worked as lab manager and senior technical specialist in the High Content Genomics and Bioinformatics unit of the Germans Trias i Pujol Research Institute (IGTP) (2016-2023). During these 14 years she participated in numerous research projects offering scientific-technical services to different research groups, using microarray technology and massive sequencing platforms from Illumina and Ion Torrent.
She has extensive experience in high-throughput genomic technologies, including NGS techniques such as RNAseq, smallRNAseq, exome sequencing, targeted re-sequencing, amplicon and WGS; SNP and CNV genotyping techniques, DNA methylation analysis using Illumina beadarrays; and comparative genomic hybridisation (CGH) techniques, and RNA and miRNA expression using Agilent microarrays.
In September 2023 she joined IJC as head of the Genomics Unit.